Expanded Access to NanoPac for Patients Not Eligible for Current Clinical Trials

Sponsor: NanOlogy, LLC

Expanded Access

Sponsor score: 40

Inactive

ClinicalTrials ID:NCT03756311

NanOlogy is considering providing access to NanoPac for patients who cannot join ongoing clinical trials due to not meeting the required criteria.

Patient Parameters

Parameter	Options

Program Overview

This program is designed to offer NanoPac, a treatment under investigation, to patients who are unable to participate in current clinical trials because they do not meet the necessary requirements. This expanded access aims to provide an opportunity for those patients to receive the treatment outside of the standard clinical trial setting.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.